Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection

• Published in: European journal of case reports in internal medicine Vol. 7; no. 7; p. 001769
• Main Authors: Lorenzo-Villalba, Noel, Maouche, Yasmine, Syrovatkova, Aneska, Pham, Felix, Chahbazian, Jean-Baptiste, Pertoldi, Pierre, Andrès, Emmanuel, Zulfiqar, Abrar-Ahmad
• Format: Journal Article
• Language: English
• Published: Italy SMC Media Srl 2020; SMC MEDIA SRL
• Subjects: coagulation abnormalities; covid-19; dermatoporosis; dissecting haematoma; COVID-19; coagulation abnormalities; dissecting haematoma; dermatoporosis
• ISSN: 2284-2594; 2284-2594
• DOI: 10.12890/2020_001769

We describe the case of a patient hospitalized for acute decompensated heart failure in a standard medical ward. During hospitalization, he was diagnosed with COVID-19 and transferred to a special unit. The clinical course was marked by worsening of the respiratory disease, the development of right parotiditis and thrombosis of the left internal jugular vein. Therapeutic anticoagulation was initiated and 2 days later, the minimal dermatoporosis lesions previously present in the upper extremities evolved to haemorrhagic bullae with intra-bullae blood clots and dissecting haematomas. Surgical management of the dissecting haematomas was difficult in the context of haemostasis abnormalities. The patient died 29 days after hospital admission.
Single room accommodation should be preferred to double room accommodation in standard wards during the COVID-19 pandemic.Anticoagulation therapy and the presence of lupus anticoagulant may induce cutaneous complications during COVID-19 infection.The discontinuation of anticoagulation therapy did not help improve the management of cutaneous lesions.